Gabapentin Monotherapy for Refractory Seizures

Abstract

The results of an 8-day, controlled, multicenter study of gabapentin monotherapy in 82 hospitalized patients with refractory complex partial or secondarily generalized seizures are reported by members of the US Gabapentin Study Group.

Keywords

• gabapentin monotherapy
• antiepileptic medications
• prolonged/intensified seizures